54gene, the African genomics research, services, and development company has closed a Series A round of $15 million, led by Adjuvant Capital, including Raba Capital, V8 Capital, Ingressive Capital, and follow on investment from Y Combinator, Better Ventures, Fifty Years, KdT Ventures, Aera VC and Pioneer Fund. Founder and CEO, Dr Abasi Ene-Obong says…